Drug Shortage Report for METVIX
| Report ID | 193468 |
| Drug Identification Number | 02323273 |
| Brand name | METVIX |
| Common or Proper name | methyl aminolevulinate |
| Company Name | GALDERMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHYL AMINOLEVULINATE |
| Strength(s) | 168MG |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 2 g |
| ATC code | L01XD |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-05-31 |
| Actual start date | 2023-05-31 |
| Estimated end date | 2023-07-15 |
| Actual end date | 2023-07-07 |
| Shortage status | Resolved |
| Updated date | 2023-07-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 COMMERCE VALLEY DRIVE WEST THORNHILL, ONTARIO CANADA L3T 7V9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-07-10 | French | Compare |
| v4 | 2023-07-10 | English | Compare |
| v3 | 2023-06-01 | English | Compare |
| v2 | 2023-05-31 | French | Compare |
| v1 | 2023-05-31 | English | Compare |
Showing 1 to 5 of 5